Gorgannezhad L, Sreejith K, Zhang J, Kijanka G, Christie M, Stratton H
Micromachines (Basel). 2020; 10(12).
PMID: 31888270
PMC: 6952809.
DOI: 10.3390/mi10120883.
Sampaio C, Biondo-Simoes M, Trindade L, Olandowski M, Matias J
Acta Cir Bras. 2019; 34(1):e20190010000004.
PMID: 30785505
PMC: 6585925.
DOI: 10.1590/s0102-865020190010000004.
Jokipii A, Jokipii L
Infection. 1980; 8(3):101-3.
PMID: 7419273
DOI: 10.1007/BF01641471.
Heimdahl A, Nord C, Okuda K
Med Microbiol Immunol. 1980; 168(1):1-10.
PMID: 7382911
DOI: 10.1007/BF02121647.
URSING B, Nilsson-Ehle P
Antimicrob Agents Chemother. 1981; 19(5):754-60.
PMID: 7294765
PMC: 181517.
DOI: 10.1128/AAC.19.5.754.
A comparison of the pharmacokinetics of metronidazole in man after oral administration of single doses of benzoylmetronidazole and metronidazole.
Houghton G, Hundt H, Muller F, Templeton R
Br J Clin Pharmacol. 1982; 14(2):201-6.
PMID: 7104172
PMC: 1427741.
DOI: 10.1111/j.1365-2125.1982.tb01962.x.
Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.
Guay D, Meatherall R, Baxter H, Jacyk W, Penner B
Antimicrob Agents Chemother. 1984; 25(3):306-10.
PMID: 6721462
PMC: 185505.
DOI: 10.1128/AAC.25.3.306.
Clinical pharmacokinetics of metronidazole.
Ralph E
Clin Pharmacokinet. 1983; 8(1):43-62.
PMID: 6340904
DOI: 10.2165/00003088-198308010-00003.
Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.
Lau A, Lam N, Piscitelli S, Wilkes L, Danziger L
Clin Pharmacokinet. 1992; 23(5):328-64.
PMID: 1478003
DOI: 10.2165/00003088-199223050-00002.
Letter: Brain abscess.
Ingham H, Selkon J, So S, Weiser R
Br Med J. 1975; 4(5987):39-40.
PMID: 1174915
PMC: 1674743.
DOI: 10.1136/bmj.4.5987.39-a.
Metronidazole and anaerobic sepsis.
Eykyn S, Phillips I
Br Med J. 1976; 2(6049):1418-21.
PMID: 1009357
PMC: 1690376.
DOI: 10.1136/bmj.2.6049.1418.
Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.
Wust J
Antimicrob Agents Chemother. 1977; 11(4):631-7.
PMID: 856015
PMC: 352041.
DOI: 10.1128/AAC.11.4.631.
Metronidazole in prevention and treatment of bacteroides infections after appendicectomy.
Willis A, FERGUSON I, Jones P, Phillips K, Tearle P, Berry R
Br Med J. 1976; 1(6005):318-21.
PMID: 764935
PMC: 1638715.
DOI: 10.1136/bmj.1.6005.318.
Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.
Goldstein E, Sutter V, Finegold S
Antimicrob Agents Chemother. 1978; 14(4):609-13.
PMID: 718156
PMC: 352515.
DOI: 10.1128/AAC.14.4.609.
Access of metronidazole into the chronically inflamed middle ear with reference to anaerobic bacterial infections.
Jokipii L, Karma P, Jokipii A
Arch Otorhinolaryngol. 1978; 220(3):167-74.
PMID: 581160
DOI: 10.1007/BF00457484.
Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose.
Houghton G, Thorne P, Smith J, Templeton R, Collier J
Br J Clin Pharmacol. 1979; 8(4):337-41.
PMID: 508508
PMC: 1429835.
DOI: 10.1111/j.1365-2125.1979.tb04715.x.
Treatment of infections due to nonsporing anaerobes.
Sprott M, Ingham H
Drugs. 1979; 18(2):137-49.
PMID: 487957
DOI: 10.2165/00003495-197918020-00006.
Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.
Brogden R, Heel R, Speight T, Avery G
Drugs. 1978; 16(5):387-417.
PMID: 363399
DOI: 10.2165/00003495-197816050-00002.
Metronidazole bioassay with increased sensitivity.
Jokipii L, Jokipii A
Med Microbiol Immunol. 1979; 167(1):61-70.
PMID: 220515
DOI: 10.1007/BF02123297.
Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole.
Rissing J, Newman C, Moore Jr W
Antimicrob Agents Chemother. 1978; 14(4):636-8.
PMID: 214030
PMC: 352522.
DOI: 10.1128/AAC.14.4.636.
